$58.17
4.889.16%
Last update: Nov 9, 5:14 PM
Pulse Biosciences Inc
PLSENASDAQ
Pulse Biosciences rose 278.8% from $15.36 to a 1-year high of $58.17, ahead of the S&P 500's +10.5%. Its worst day was Feb 20 (−14.6%), and its low came Nov 20 at $12.66.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Pulse Biosciences closed at its lowest level of the year, 17.6% below where the year started.
−2.7% · S&P 500 −1.5%
Story events cover the past 12 months · Times ET
Procedural success was achieved in 100% of evaluable patients at 6 months and 96% in 12 months
+51.6%, the year's best day, on 3M shares, the year's heaviest volume · S&P 500 +1.9%
EPS of $-0.26 missed the $-0.25 estimate on $264,000.00 revenue (est. $250,000.00).
−14.6%, the year's worst day · S&P 500 +0.7%
EPS of $-0.27 missed the $-0.24 estimate on $401,000.00 revenue (est. $420,000.00).
−3.8% · S&P 500 −0.4%
Pulse Biosciences shares rose 22.1%, while the S&P 500 fell 0.2%.
+22.1% · S&P 500 −0.2%
EPS of $-0.36 missed the $-0.29 estimate on $434,000.00 revenue (est. $566,664.00).
+10.9% · S&P 500 +0.6%
EPS of $-0.32 missed the $-0.30 estimate on $395,000.00 revenue (est. $517,336.00).
+0.4% · S&P 500 +0.3%
Where it ended: a 1-year high close of $58.17 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 18, 2027 (EPS est. $-0.27, revenue est. $620,000.00).
Nothing in the past 12 months.
All PLSE dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for PLSE and SPY from Benzinga historical bars. Not investment advice.
